文献速递心脑血管急症重症综合管理与镇静镇痛

高血压急症合并心衰的降压策略比较

Comparing antihypertensive strategies in hypertensive emergencies with heart failure.
PubMed 文献 · Am J Emerg Med · 2024-12-09
一句话结论回顾性队列显示高血压急症合并心衰时,口服、静脉推注、持续静脉输注或联合方案达到目标血压无显著差异,静脉推注与更短ICU住院相关。

该回顾性队列研究纳入2019至2021年高血压急症合并心衰加重的120例入院患者,分为仅口服药、静脉推注、持续静脉输注(CIVI)及CIVI联合静脉推注四组。主要终点为收缩压下降25%或血压<160/110 mmHg所需时间,各组达标无显著差异(ANOVA p=0.662),CIVI有达标最快的非显著趋势。静脉推注组ICU住院天数显著少于CIVI组,总住院时长无显著变化。急性肾损伤最常见(31例,25.83%),组间无差异(p=0.825)。结论认为任何方式均可充分管理,静脉推注与更短ICU住院相关。

要点

  • 高血压急症合并心衰患者中,仅口服药、静脉推注、CIVI或CIVI联合静脉推注四组达到目标血压(收缩压下降25%或<160/110 mmHg)无显著差异(ANOVA p=0.662)。
  • CIVI有达到目标血压最快的非显著趋势。
  • 静脉推注组ICU住院天数显著少于CIVI组,总住院时长无显著变化。
  • 急性肾损伤最常见,发生于31例(25.83%),组间无差异(p=0.825)。
  • 作者认为高血压急症可能不如既往认为的那么具有临床意义。

适用人群与场景

  • 2019至2021年因高血压急症合并心衰加重入院的患者,共分析120例入院(初始审查1041例,应用排除标准后纳入)。

诊断标准与关键阈值

  • 目标血压:收缩压下降25%或血压<160/110 mmHg。

处置流程与药物剂量

  • 患者分为四组:仅口服药物、静脉推注、持续静脉输注(CIVI)、CIVI联合静脉推注。
  • 静脉推注组与CIVI组相比,ICU住院天数显著更少,总住院时长无显著变化。

研究设计与关键结果

  • 回顾性队列研究,分析120例入院,比较四种降压策略。
  • 达到目标血压时间组间无显著差异(ANOVA p=0.662)。
  • CIVI有达标最快的非显著趋势。
  • 静脉推注组ICU住院天数显著少于CIVI组,总住院时长无显著变化。
  • 急性肾损伤最常见,31例(25.83%),组间无差异(p=0.825)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为高血压急症合并心衰可用任何治疗方式充分管理。
  • 作者指出静脉推注治疗与更短ICU住院时长相关。
  • 作者认为高血压急症可能不如既往认为的那么具有临床意义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: 6.2 million Americans live with heart failure (HF) and are at risk for hospitalization due to hypertensive emergencies. Optimal treatment strategy for acute hypertensive heart failure remains unclear. Our study investigates what treatment modality is most effective in achieving guideline-directed blood pressure control.

METHODS: This was a retrospective cohort study of hypertensive emergency with HF exacerbation from 2019 to 2021. The primary outcome was length of time for a 25 % decrease in systolic BP or BP of <160/110 mmHg. Patients were categorized into 4 groups: only oral medications, IV bolus, continuous IV infusion (CIVI), or both CIVI and IV bolus.

RESULTS: A total of 120 admissions were analyzed after applying exclusion criteria to a total of 1041 reviewed. Groups were well balanced and similar in characteristics. There were no significant differences in achieving the target BP among groups (ANOVA p = 0.662). CIVI had a nonsignificant trend towards achieving target BP fastest, however, IV bolus administration resulted in significantly fewer days in ICU compared to CIVI without a significant change in total hospital length of stay. Acute kidney injury was the most common complication, occuring in 31 (25.83 %) patients without differences across groups (p = 0.825).

CONCLUSIONS: Acute hypertensive heart failure was managed adequately with any treatment modality. Use of IV bolus therapy in these patients was associated with shorter ICU length of stay. Our results add to growing evidence that hypertensive emergencies may be less clinically significant than previously thought.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Bronstein D, Holman M, Wu R, et al. Comparing antihypertensive strategies in hypertensive emergencies with heart failure. Am J Emerg Med. 2024. PMID: 39667139. doi:10.1016/j.ajem.2024.12.001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。